Healthcare Trust Confirms Series A Preferred Stock Registration

Ticker: NHPBP · Form: 8-K · Filed: Jan 3, 2024 · CIK: 1561032

Healthcare Trust, Inc. 8-K Filing Summary
FieldDetail
CompanyHealthcare Trust, Inc. (NHPBP)
Form Type8-K
Filed DateJan 3, 2024
Risk Levellow
Pages3
Reading Time4 min
Key Dollar Amounts$0.01, $14.00, $0.85, $0.2125
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: regulatory-filing, preferred-stock, compliance

TL;DR

**HTI's Series A Preferred Stock is officially registered for public trading.**

AI Summary

Healthcare Trust, Inc. (HTI) filed an 8-K on January 3, 2024, to report that its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, with a $0.01 par value per share, is registered under Section 12(b) of the Securities Exchange Act of 1934. This filing is a routine update confirming the registration status of its preferred stock, which is important for investors as it ensures the stock can be publicly traded on an exchange. For current or potential investors, this confirms the preferred stock's listing and regulatory compliance, providing transparency and liquidity.

Why It Matters

This filing confirms the regulatory status of Healthcare Trust's Series A Preferred Stock, ensuring it can be traded on an exchange and providing transparency for investors.

Risk Assessment

Risk Level: low — This filing is a routine administrative update and does not indicate any new financial or operational risks for the company.

Analyst Insight

Investors in Healthcare Trust, Inc. should note this filing as a routine compliance update, confirming the continued public trading status of their Series A Preferred Stock. No immediate action is required based on this administrative filing.

Key Numbers

  • $0.01 — Par Value per Share (The stated par value of the Series A Preferred Stock.)
  • 7.375% — Dividend Rate (The fixed dividend rate for the Series A Cumulative Redeemable Perpetual Preferred Stock.)

Key Players & Entities

  • Healthcare Trust, Inc. (company) — the registrant filing the 8-K
  • 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (other) — the specific security mentioned in the filing
  • $0.01 (dollar_amount) — par value per share of the preferred stock
  • January 3, 2024 (date) — date of the earliest event reported and filing date

FAQ

What is the purpose of this 8-K filing by Healthcare Trust, Inc.?

The purpose of this 8-K filing by Healthcare Trust, Inc. is to report that its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, with a $0.01 par value per share, is registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, confirming its listing status.

What specific type of security is mentioned in this filing?

The specific type of security mentioned in this filing is the '7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share'.

What is the par value per share of the preferred stock mentioned?

The par value per share of the preferred stock mentioned is $0.01.

Under which section of the Securities Exchange Act of 1934 is the preferred stock registered?

The preferred stock is registered pursuant to Section 12(b) of the Securities Exchange Act of 1934.

What was the date of the earliest event reported in this 8-K filing?

The date of the earliest event reported in this 8-K filing was January 3, 2024.

Filing Stats: 913 words · 4 min read · ~3 pages · Grade level 12.3 · Accepted 2024-01-03 16:30:24

Key Financial Figures

  • $0.01 — e Redeemable Perpetual Preferred Stock, $0.01 par value per share HTIA The Nasdaq G
  • $14.00 — the applicable date, which is currently $14.00 per share, based on a single record dat
  • $0.85 — be based on a per share amount equal to $0.85 per annum, or $0.2125 per quarter. Plea
  • $0.2125 — are amount equal to $0.85 per annum, or $0.2125 per quarter. Please see the Company's C

Filing Documents

01. Other Events

Item 8.01. Other Events . Common Stock Dividend On January 3, 2024, Healthcare Trust, Inc. (the "Company") announced the declaration of a quarterly stock dividend of 0.015179 shares of the Company's common stock, $0.01 par value per share (the "Common Stock"), on each share of the Company's outstanding Common Stock. The stock dividend is payable on January 16, 2024 to holders of record of the Company's Common Stock at the close of business on January 12, 2024. As previously announced, dividends authorized by the Company's board of directors on the Company's shares of Common Stock will be paid on a quarterly basis in arrears in shares of the Company's Common Stock valued at the Company's estimated per share net asset value of Common Stock in effect on the applicable date, which is currently $14.00 per share, based on a single record date to be specified at the beginning of each quarter. The number of shares to be so issued will continue to be based on a per share amount equal to $0.85 per annum, or $0.2125 per quarter. Please see the Company's Current Report on Form 8-K filed with the SEC on March 31, 2023 for a full description of the determination of the Company's current estimated per share net asset value of Common Stock and related assumptions, qualifications and limitations.

Forward-Looking Statements

Forward-Looking Statements The statements in this Current Report on Form 8-K that are not historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 . These forward-looking statements involve risks and uncertainties that could cause actual results or events to be materially different. The words "anticipates," "believes," "expects," "estimates," "projects," "plans," "intends," "may," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are subject to a number of risks, uncertainties and other factors, many of which are outside of the Company's control, which could cause actual results to differ materially from the results contemplated by the forward-looking actions taken to contain or treat COVID-19, (ii) the geopolitical instability due to the ongoing military conflict between Russia and Ukraine and Israel and Hamas, including related sanctions and other penalties imposed by the U.S. and European Union, and the related impact on the Company, the Company's tenants, the Company's operators and the global economy and financial markets, and (iii) inflationary conditions and higher interest rate environments, as well as those risks and uncertainties set forth in the Risk Factors section of the Company's Annual Report on Form 10-K for the year ended December 31, 2022 filed on March 17, 2023, and all other filings with the Securities and Exchange Commission after that date, as such risks, uncertainties and other important factors may be updated from time to time in the Company's subsequent filings with the Securities and Exchange Commission. Further, forward-looking statements speak only as of the date they are made,

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEALTHCARE TRUST, INC. Date: January 3, 2024 By: /s/ Scott M. Lappetito Scott M. Lappetito Chief Financial Officer, Secretary and Treasurer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.